Long-term survival after central nervous system relapse in a patient with osteosarcoma

Cancer. 1993 Aug 15;72(4):1203-8. doi: 10.1002/1097-0142(19930815)72:4<1203::aid-cncr2820720412>3.0.co;2-p.

Abstract

Background: Since the advent of multiagent adjuvant chemotherapy, survival among patients with localized osteosarcoma has improved to 60% or more. Pulmonary relapse, the most common cause of treatment failure, is associated with less than 25% long-term survival; central nervous system (CNS) metastasis, when it occurs, often presents as a catastrophic clinical event in preterminal patients.

Methods: The authors report a patient with osteosarcoma who had an isolated pulmonary relapse and a subsequent isolated CNS relapse. Complete surgical resection was accomplished on both occasions and followed in the initial instance by adjuvant chemotherapy and in the latter instance by adjuvant whole-brain irradiation.

Results: An isolated CNS metastasis was resected and adjuvant whole brain irradiation was administered; the patient is alive and relapse free more than 5 years later.

Conclusions: Patients with osteosarcoma in whom isolated, resectable metastases develop can derive benefit from gross total resection followed by adjuvant chemotherapy or radiation therapy for microscopic residual disease.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Brain Neoplasms / mortality
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / therapy
  • Child
  • Combined Modality Therapy
  • Female
  • Femoral Neoplasms* / mortality
  • Femoral Neoplasms* / therapy
  • Humans
  • Lung Neoplasms / secondary
  • Lung Neoplasms / therapy
  • Osteosarcoma / mortality
  • Osteosarcoma / secondary*
  • Osteosarcoma / therapy
  • Time Factors